AT285043B - Verfahren zur Herstellung eines neuen Enzyminhibitors - Google Patents

Verfahren zur Herstellung eines neuen Enzyminhibitors

Info

Publication number
AT285043B
AT285043B AT425669A AT425669A AT285043B AT 285043 B AT285043 B AT 285043B AT 425669 A AT425669 A AT 425669A AT 425669 A AT425669 A AT 425669A AT 285043 B AT285043 B AT 285043B
Authority
AT
Austria
Prior art keywords
preparation
enzyme inhibitor
new enzyme
new
inhibitor
Prior art date
Application number
AT425669A
Other languages
English (en)
Original Assignee
Rhone Poulenc Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sa filed Critical Rhone Poulenc Sa
Application granted granted Critical
Publication of AT285043B publication Critical patent/AT285043B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/005Enzyme inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8142Aspartate protease (E.C. 3.4.23) inhibitors, e.g. HIV protease inhibitors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/886Streptomyces
    • Y10S435/898Streptomyces hygroscopicus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • AIDS & HIV (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT425669A 1968-05-03 1969-05-02 Verfahren zur Herstellung eines neuen Enzyminhibitors AT285043B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR150509 1968-05-03

Publications (1)

Publication Number Publication Date
AT285043B true AT285043B (de) 1970-10-12

Family

ID=8649780

Family Applications (1)

Application Number Title Priority Date Filing Date
AT425669A AT285043B (de) 1968-05-03 1969-05-02 Verfahren zur Herstellung eines neuen Enzyminhibitors

Country Status (10)

Country Link
US (1) US3629404A (de)
AT (1) AT285043B (de)
BE (1) BE732465A (de)
BR (1) BR6908459D0 (de)
CH (1) CH515328A (de)
DE (1) DE1922601A1 (de)
DK (1) DK123246B (de)
FR (1) FR1593504A (de)
GB (1) GB1216295A (de)
NL (1) NL6906434A (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4013510A (en) * 1970-12-28 1977-03-22 Farbenfabriken Bayer Aktiengesellschaft Glycoside-hydrolase enzyme inhibitors
US3951745A (en) * 1970-12-28 1976-04-20 Farbenfabriken Bayer Aktiengesellschaft Glycoside-hydrolase enzyme inhibitors
US3937817A (en) * 1973-02-28 1976-02-10 Bayer Aktiengesellschaft Pharmaceutical compositions containing a saccharase inhibitor
JPS5413516B2 (de) * 1973-09-11 1979-05-31
US3992528A (en) * 1975-02-18 1976-11-16 Research Corporation Anti-viral substance containing peptide, fatty acid and carbohydrate moieties
JPS608117B2 (ja) * 1977-02-08 1985-02-28 財団法人微生物化学研究会 新生理活性物質エステラスチンおよびその製造法
JPS53109997A (en) * 1977-03-04 1978-09-26 Sankyo Co Ltd Antibiotic substance no.17927 a2

Also Published As

Publication number Publication date
DK123246B (da) 1972-05-29
DE1922601A1 (de) 1970-08-27
CH515328A (fr) 1971-11-15
FR1593504A (de) 1970-06-01
BR6908459D0 (pt) 1973-07-03
GB1216295A (en) 1970-12-16
NL6906434A (de) 1969-11-05
BE732465A (fr) 1969-11-03
US3629404A (en) 1971-12-21

Similar Documents

Publication Publication Date Title
CH538473A (de) Verfahren zur Herstellung eines 1-substituierten 3-Phenoxypyrrolidins
AT303967B (de) Verfahren zur Herstellung eines neuen 5-Phenylazosalicylsäurederivates
CH498122A (de) Verfahren zur Herstellung eines neuen Tetrahydroazepinderivates
AT283353B (de) Verfahren zur Herstellung von neuen N-Tritylimidazolderivaten
AT307448B (de) Verfahren zur Herstellung eines neuen Dipeptids
AT305491B (de) Verfahren zur Herstellung eines neuen Kombinationspräparates
AT287732B (de) Verfahren zur Herstellung von neuen Thioninderivaten
AT319172B (de) Verfahren zur Herstellung eines Saccharaseinhibitors
CH523269A (de) Verfahren zur Herstellung von neuen Imidazolidinochinazolinderivaten
AT285043B (de) Verfahren zur Herstellung eines neuen Enzyminhibitors
AT291450B (de) Verfahren zur Herstellung neuen 16α-Hydroxy-17α-aminosteroiden
AT301021B (de) Verfahren zur Herstellung des neuen Erythromycylamins
AT285065B (de) Verfahren zur Herstellung eines neuen Pentacosapeptids
AT286284B (de) Verfahren zur Herstellung von neuen 7-Cyan-cumarinderivaten
AT293358B (de) Verfahren zur Herstellung von neuen N-Acyl-hydroxylaminderivaten
AT303253B (de) Verfahren zur Herstellung eines neuen Amylase-Inhibitors
CH538540A (de) Verfahren zur Herstellung eines Enzympräparates
CH537915A (de) Verfahren zur Herstellung eines neuen Östratriols
AT319170B (de) Verfahren zur Herstellung eines Amylaseinhibitors
AT311570B (de) Verfahren zur Herstellung eines neuen 6α-Methyl-19-nor-progesterons
CH509333A (de) Verfahren zur Herstellung eines Gemisches von Triazinyl-aminostilbenderivaten
CH513110A (de) Verfahren zur Herstellung von neuen Bis-alkanolamin-Derivaten
CH517762A (de) Verfahren zur Herstellung eines neuen D-6-Methylergolenderivates
AT300195B (de) Verfahren zur Herstellung eines neuen Antibioticums
CH535584A (de) Verfahren zur Herstellung eines Proteaseinhibitors

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee